Cetera Investment Advisers Ocular Therapeutix, Inc Call Options Transaction History

Cetera Investment Advisers

  • $55.9 Billion
  • Q2 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$2.08 - $4.52 $10,400 - $22,599
5,000 New
5,000 $22,000
Q2 2023

Aug 09, 2023
BUY
$4.6 - $7.64 $69,000 - $114,600
15,000 New
15,000 $77,000
Q3 2022

Nov 10, 2022
BUY
$4.09 - $6.5 $20,450 - $32,500
5,000 New
5,000 $3,000
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $61,600 - $120,700
10,000 New
10,000 $19,000

Others Institutions Holding OCUL

# of Institutions
204
Shares Held
137M
Call Options Held
743K
Put Options Held
321K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $919M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email